Chemical conjugation of a novel antibody-interleukin 2 immunoconjugate against c-erbB-2 product
To develop a new chemical method to produce a monoclonal antibody (MoAb) 520C9/recombinant human interleukin 2 (rhIL-2) conjugate. MoAb 520C9 reactive with the protooncogene c-erbB-2 product P185 was chemically conjugated with rhIL-2 by using a simple two-step method. First, the rhIL-2 was activated...
Gespeichert in:
Veröffentlicht in: | Chinese medical journal 2000-02, Vol.113 (2), p.151-153 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 153 |
---|---|
container_issue | 2 |
container_start_page | 151 |
container_title | Chinese medical journal |
container_volume | 113 |
creator | Li, J Lee, S E Belciug, M Ring, D B Kwok, C S |
description | To develop a new chemical method to produce a monoclonal antibody (MoAb) 520C9/recombinant human interleukin 2 (rhIL-2) conjugate.
MoAb 520C9 reactive with the protooncogene c-erbB-2 product P185 was chemically conjugated with rhIL-2 by using a simple two-step method. First, the rhIL-2 was activated by Sulfosuccinimidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate, a heterobifunctional linker, and N-succinimidyl s-acetylthioacetate was introduced onto 520C9. Then SATA on the 520C9 was reacted with the maleimide group on the activated rhIL-2 to generate 520C9-rhIL-2 immunoconjugate.
The immunoconjugate retained the antigen binding activity compared to the respective native antibody as determined by an indirect live cell binding assay. The immunoconjugate also possessed IL-2 activity as measured by the standard CTLL-2 cells proliferation assay and the stimulation of human peripheral blood mononuclear cells (PBMCs) into lymphokine-activated killer cells.
Our method of conjugation of rhIL-2 to 520C9 preserves the binding activity of the antibody and the cytokine function of IL-2. This simple and efficient method of conjugation should be applicable to other types of MoAbs and recombinant cytokines. |
format | Article |
fullrecord | <record><control><sourceid>wanfang_jour_proqu</sourceid><recordid>TN_cdi_wanfang_journals_zhcmj200002014</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><wanfj_id>zhcmj200002014</wanfj_id><sourcerecordid>zhcmj200002014</sourcerecordid><originalsourceid>FETCH-LOGICAL-p238t-7a08c3181f8c4d4f43058fad960ae6bfaec405e32ff4a5967cbd5c3a0fc5b7f23</originalsourceid><addsrcrecordid>eNpFkMtOwzAURL0A0VL4BeQVu0iOX0mWUPGSKrGBtXXj2K1DbJc4BpWvJxKtmM1szsy9mjO0JEzKQjZNs0CXKfWEUCEqeYEWZVlVQvByidR6Z7zTMGAdQ5-3MLkYcLQYcIhfZsAQJtfG7lC4MJlxMPnDBUyx8z6HeMoYDFtwIU1YF2Zs7wuK92Pssp6u0LmFIZnro6_Q--PD2_q52Lw-vazvNsWesnoqKiC1ZmVd2lrzjlvOiKgtdI0kYGRrwWhOhGHUWg6ikZVuO6EZEKtFW1nKVuj2r_cbgoWwVX3MY5gvqp-d9j0lsygp-T84P_iZTZqUd0mbYYBgYk6qIqKUnMsZvDmCufWmU_vReRgP6rQd-wWMfmrR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70516446</pqid></control><display><type>article</type><title>Chemical conjugation of a novel antibody-interleukin 2 immunoconjugate against c-erbB-2 product</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Li, J ; Lee, S E ; Belciug, M ; Ring, D B ; Kwok, C S</creator><creatorcontrib>Li, J ; Lee, S E ; Belciug, M ; Ring, D B ; Kwok, C S</creatorcontrib><description>To develop a new chemical method to produce a monoclonal antibody (MoAb) 520C9/recombinant human interleukin 2 (rhIL-2) conjugate.
MoAb 520C9 reactive with the protooncogene c-erbB-2 product P185 was chemically conjugated with rhIL-2 by using a simple two-step method. First, the rhIL-2 was activated by Sulfosuccinimidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate, a heterobifunctional linker, and N-succinimidyl s-acetylthioacetate was introduced onto 520C9. Then SATA on the 520C9 was reacted with the maleimide group on the activated rhIL-2 to generate 520C9-rhIL-2 immunoconjugate.
The immunoconjugate retained the antigen binding activity compared to the respective native antibody as determined by an indirect live cell binding assay. The immunoconjugate also possessed IL-2 activity as measured by the standard CTLL-2 cells proliferation assay and the stimulation of human peripheral blood mononuclear cells (PBMCs) into lymphokine-activated killer cells.
Our method of conjugation of rhIL-2 to 520C9 preserves the binding activity of the antibody and the cytokine function of IL-2. This simple and efficient method of conjugation should be applicable to other types of MoAbs and recombinant cytokines.</description><identifier>ISSN: 0366-6999</identifier><identifier>PMID: 11775541</identifier><language>eng</language><publisher>China</publisher><subject>Animals ; Antibodies, Monoclonal - chemistry ; Cell Division - drug effects ; Cell Division - immunology ; Cell Line ; Cells, Cultured ; Electrophoresis, Polyacrylamide Gel ; Humans ; Immunoconjugates - isolation & purification ; Immunoconjugates - metabolism ; Immunoconjugates - pharmacology ; Interleukin-2 - chemistry ; Protein Binding ; Receptor, ErbB-2 - immunology ; Recombinant Proteins - chemistry ; Tumor Cells, Cultured</subject><ispartof>Chinese medical journal, 2000-02, Vol.113 (2), p.151-153</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.wanfangdata.com.cn/images/PeriodicalImages/zhcmj/zhcmj.jpg</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11775541$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, J</creatorcontrib><creatorcontrib>Lee, S E</creatorcontrib><creatorcontrib>Belciug, M</creatorcontrib><creatorcontrib>Ring, D B</creatorcontrib><creatorcontrib>Kwok, C S</creatorcontrib><title>Chemical conjugation of a novel antibody-interleukin 2 immunoconjugate against c-erbB-2 product</title><title>Chinese medical journal</title><addtitle>Chin Med J (Engl)</addtitle><description>To develop a new chemical method to produce a monoclonal antibody (MoAb) 520C9/recombinant human interleukin 2 (rhIL-2) conjugate.
MoAb 520C9 reactive with the protooncogene c-erbB-2 product P185 was chemically conjugated with rhIL-2 by using a simple two-step method. First, the rhIL-2 was activated by Sulfosuccinimidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate, a heterobifunctional linker, and N-succinimidyl s-acetylthioacetate was introduced onto 520C9. Then SATA on the 520C9 was reacted with the maleimide group on the activated rhIL-2 to generate 520C9-rhIL-2 immunoconjugate.
The immunoconjugate retained the antigen binding activity compared to the respective native antibody as determined by an indirect live cell binding assay. The immunoconjugate also possessed IL-2 activity as measured by the standard CTLL-2 cells proliferation assay and the stimulation of human peripheral blood mononuclear cells (PBMCs) into lymphokine-activated killer cells.
Our method of conjugation of rhIL-2 to 520C9 preserves the binding activity of the antibody and the cytokine function of IL-2. This simple and efficient method of conjugation should be applicable to other types of MoAbs and recombinant cytokines.</description><subject>Animals</subject><subject>Antibodies, Monoclonal - chemistry</subject><subject>Cell Division - drug effects</subject><subject>Cell Division - immunology</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Humans</subject><subject>Immunoconjugates - isolation & purification</subject><subject>Immunoconjugates - metabolism</subject><subject>Immunoconjugates - pharmacology</subject><subject>Interleukin-2 - chemistry</subject><subject>Protein Binding</subject><subject>Receptor, ErbB-2 - immunology</subject><subject>Recombinant Proteins - chemistry</subject><subject>Tumor Cells, Cultured</subject><issn>0366-6999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtOwzAURL0A0VL4BeQVu0iOX0mWUPGSKrGBtXXj2K1DbJc4BpWvJxKtmM1szsy9mjO0JEzKQjZNs0CXKfWEUCEqeYEWZVlVQvByidR6Z7zTMGAdQ5-3MLkYcLQYcIhfZsAQJtfG7lC4MJlxMPnDBUyx8z6HeMoYDFtwIU1YF2Zs7wuK92Pssp6u0LmFIZnro6_Q--PD2_q52Lw-vazvNsWesnoqKiC1ZmVd2lrzjlvOiKgtdI0kYGRrwWhOhGHUWg6ikZVuO6EZEKtFW1nKVuj2r_cbgoWwVX3MY5gvqp-d9j0lsygp-T84P_iZTZqUd0mbYYBgYk6qIqKUnMsZvDmCufWmU_vReRgP6rQd-wWMfmrR</recordid><startdate>20000201</startdate><enddate>20000201</enddate><creator>Li, J</creator><creator>Lee, S E</creator><creator>Belciug, M</creator><creator>Ring, D B</creator><creator>Kwok, C S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>20000201</creationdate><title>Chemical conjugation of a novel antibody-interleukin 2 immunoconjugate against c-erbB-2 product</title><author>Li, J ; Lee, S E ; Belciug, M ; Ring, D B ; Kwok, C S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p238t-7a08c3181f8c4d4f43058fad960ae6bfaec405e32ff4a5967cbd5c3a0fc5b7f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal - chemistry</topic><topic>Cell Division - drug effects</topic><topic>Cell Division - immunology</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Humans</topic><topic>Immunoconjugates - isolation & purification</topic><topic>Immunoconjugates - metabolism</topic><topic>Immunoconjugates - pharmacology</topic><topic>Interleukin-2 - chemistry</topic><topic>Protein Binding</topic><topic>Receptor, ErbB-2 - immunology</topic><topic>Recombinant Proteins - chemistry</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, J</creatorcontrib><creatorcontrib>Lee, S E</creatorcontrib><creatorcontrib>Belciug, M</creatorcontrib><creatorcontrib>Ring, D B</creatorcontrib><creatorcontrib>Kwok, C S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, J</au><au>Lee, S E</au><au>Belciug, M</au><au>Ring, D B</au><au>Kwok, C S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemical conjugation of a novel antibody-interleukin 2 immunoconjugate against c-erbB-2 product</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chin Med J (Engl)</addtitle><date>2000-02-01</date><risdate>2000</risdate><volume>113</volume><issue>2</issue><spage>151</spage><epage>153</epage><pages>151-153</pages><issn>0366-6999</issn><abstract>To develop a new chemical method to produce a monoclonal antibody (MoAb) 520C9/recombinant human interleukin 2 (rhIL-2) conjugate.
MoAb 520C9 reactive with the protooncogene c-erbB-2 product P185 was chemically conjugated with rhIL-2 by using a simple two-step method. First, the rhIL-2 was activated by Sulfosuccinimidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate, a heterobifunctional linker, and N-succinimidyl s-acetylthioacetate was introduced onto 520C9. Then SATA on the 520C9 was reacted with the maleimide group on the activated rhIL-2 to generate 520C9-rhIL-2 immunoconjugate.
The immunoconjugate retained the antigen binding activity compared to the respective native antibody as determined by an indirect live cell binding assay. The immunoconjugate also possessed IL-2 activity as measured by the standard CTLL-2 cells proliferation assay and the stimulation of human peripheral blood mononuclear cells (PBMCs) into lymphokine-activated killer cells.
Our method of conjugation of rhIL-2 to 520C9 preserves the binding activity of the antibody and the cytokine function of IL-2. This simple and efficient method of conjugation should be applicable to other types of MoAbs and recombinant cytokines.</abstract><cop>China</cop><pmid>11775541</pmid><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0366-6999 |
ispartof | Chinese medical journal, 2000-02, Vol.113 (2), p.151-153 |
issn | 0366-6999 |
language | eng |
recordid | cdi_wanfang_journals_zhcmj200002014 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Animals Antibodies, Monoclonal - chemistry Cell Division - drug effects Cell Division - immunology Cell Line Cells, Cultured Electrophoresis, Polyacrylamide Gel Humans Immunoconjugates - isolation & purification Immunoconjugates - metabolism Immunoconjugates - pharmacology Interleukin-2 - chemistry Protein Binding Receptor, ErbB-2 - immunology Recombinant Proteins - chemistry Tumor Cells, Cultured |
title | Chemical conjugation of a novel antibody-interleukin 2 immunoconjugate against c-erbB-2 product |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T07%3A34%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemical%20conjugation%20of%20a%20novel%20antibody-interleukin%202%20immunoconjugate%20against%20c-erbB-2%20product&rft.jtitle=Chinese%20medical%20journal&rft.au=Li,%20J&rft.date=2000-02-01&rft.volume=113&rft.issue=2&rft.spage=151&rft.epage=153&rft.pages=151-153&rft.issn=0366-6999&rft_id=info:doi/&rft_dat=%3Cwanfang_jour_proqu%3Ezhcmj200002014%3C/wanfang_jour_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70516446&rft_id=info:pmid/11775541&rft_wanfj_id=zhcmj200002014&rfr_iscdi=true |